Ned Sharpless, MD- Founder
Ned was trained in internal medicine at the Massachusetts General Hospital, and hematology and oncology at the Dana-Farber Cancer Institute, both at Harvard Medical School. Until recently, Ned was the Wellcome Distinguished Professor of Cancer Research at the University of North Carolina at Chapel Hill and a Director of the Lineberger Comprehensive Cancer Center. He has authored more than 100 papers and book chapters as well as 10 patents on the molecular biology of cancer and aging. His research lab discovered the beneficial effects of Pharmacological Quiescence (PQ™) with regard to protection from DNA damaging agents. Ned has been appointed a Director of National Cancer Institute in June 2017 and has step down from company board and ownership stake.
Natalia Mitin, Ph.D.- President and Co-Founder
Natalia has over 20 years of research experience developing molecular biology assays in the field of cancer research. She has a strong background in molecular biology, biochemistry and cellular biology. Prior to co-founding HealthSpan Dx, Natalia was on the faculty of Department of Pharmacology at UNC Chapel Hill. Natalia holds BS in Chemical Engineering from Mendeleev Institute of Chemical Technology in Moscow, Russia and PhD in Molecular Biology and Biochemistry from Bowling Green State University in Bowling Green, Ohio.
Lori Parro- Chief Financial Officer
Brian Coleman- Head of Business Development
Brian has over 35 years in the medical industry with leading companies including Becton-Dickinson, Johnson & Johnson and Integra Life Sciences in sales, sales management and strategic planning roles. He has been directly involved in the introduction of breakthrough/disruptive technologies including mechanical stapling, laparoscopy and ultrasonic cutting and coagulation that dramatically altered surgical practice. A significant focus in his career has been the cardiothoracic surgical arena and introduction of new technology and procedures driving enhanced patient care and outcomes. Brian graduated from Seton Hall University with BA in Communications.
Susan Strum, MS- Head of Assay Development
Susan has over 30 years of biochemical research experience in both academia and industry covering several disease areas and multiple target classes. Prior to Joining HealthSpan Dx, Susan spent the majority of her career at GlaxoWellcome and GlaxoSmithKline, Inc where she developed screening assays to progress numerous preclinical leads through the pipeline and into the clinic.
Anne Knecht, PhD- Head of Scientific & Clinical Collaborations
Anne has over 25 years of research experience in multiple molecular biological/genetic systems, with experience ranging from designing and conducting experiments to analyzing data and managing the laboratory of several Howard Hughes-funded researchers.
Amy Entwsitle, MS- Head of Product Management
Susan Walker, MS- Biostatistics
Sue has more than 20 years experience in statistical analysis of clinical trial data for products in various stages of development and regulatory approval pathways at GSK, Pharmasset Inc, and United Therapeutics. Sue holds MS in Math/Statistics from Clemson University.